Concepedia

Aravind Anandam

AA

Statistics

Publications

4

Citations

86

H-Index

4

Active since

2010

Affiliations

Bristol-Myers Squibb (United States)(Current)

Biocon (India)

Bristol-Myers Squibb (India)

Aravind Anandam is an author at Bristol-Myers Squibb (United States) specializing in tumor biology, cancer research, and immunology.

Top concepts

Publications per year

2010–2021

4

Publications

4

Preparation, in vitro characterization, pharmacokinetic, and pharmacodynamic evaluation of chitosan-based plumbagin microspheres in mice bearing B16F1 melanoma

Sunil Kumar Mandala Rayabandla, Kiran Aithal, Aravind Anandam et al. · Drug Delivery · 2010 · 34 citations

Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent

Upender Velaparthi, Chetan Padmakar Darne, Jayakumar Warrier et al. · ACS Medicinal Chemistry Letters · 2020 · 27 citations · Full text

Abstract 1727: Antitumor activity associated with dual targeting of CD38 and programmed death-1 (PD-1) pathways in preclinical models

Natalie Bezman, Michelle Kinder, Amy Jhatakia et al. · Cancer Research · 2018 · 13 citations

, , +24

Discovery of Imidazopyridines as Potent Inhibitors of Indoleamine 2,3-Dioxygenase 1 for Cancer Immunotherapy

Liping Zhang, Emily C. Cherney, Xiao Zhu et al. · ACS Medicinal Chemistry Letters · 2021 · 12 citations · Full text

, , +14

1–4 of 4